- Report
- June 2023
- 65 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- February 2023
- 90 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- November 2022
- 33 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Map
- November 2022
Europe
- Report
- August 2022
- 180 Pages
Global
From €5377EUR$6,000USD£4,613GBP
- Report
- February 2022
- 77 Pages
Global
From €2196EUR$2,450USD£1,884GBP
- Report
- January 2022
- 194 Pages
Global
From €1972EUR$2,200USD£1,691GBP
- Report
- January 2022
- 243 Pages
Europe
From €4974EUR$5,550USD£4,267GBP
- Report
- January 2024
- 109 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Report
- November 2025
- 132 Pages
Global
From €851EUR$950USD£730GBP
- Report
- November 2025
- 132 Pages
Global
From €851EUR$950USD£730GBP
- Report
- November 2025
- 132 Pages
Global
From €851EUR$950USD£730GBP
- Report
- November 2025
- 132 Pages
Global
From €851EUR$950USD£730GBP
- Report
- November 2025
- 132 Pages
Global
From €851EUR$950USD£730GBP
- Report
- July 2024
- 132 Pages
Global
From €851EUR$950USD£730GBP
- Report
- January 2024
Global
From €3137EUR$3,500USD£2,691GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more